comparison of intravenous sodium valproate versus subcutaneous sumatriptan and intramuscular metoclopramide for treatment of acute migraine attacks
Phase 2
- Conditions
- migraine without aura.Migraine without aura [common migraine]
- Registration Number
- IRCT201104096154N1
- Lead Sponsor
- Guilan University of Medical Science, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
inclusion criteria include :fulfilling international headache society criteria for migraine without aura; absence of cardiovascular disease; absence of cerebrovascular disease; absence of drug allergy; absence of pregnancy; age between 16 to70 year-old.
Exclusion criteria include :occurrence of serious adverse drug effects at any time during drug administration.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Headache severity. Timepoint: before treatment,after 2, 4 , and 24 hours. Method of measurement: visual analog scale.
- Secondary Outcome Measures
Name Time Method Side effects profile. Timepoint: before treatment ,after 2 , 4, and 24 hours. Method of measurement: history taking and physical examination.